NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 316 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,266,813 | +315.2% | 132,330 | +278.8% | 0.00% | – |
Q1 2024 | $545,956 | -4.1% | 34,930 | -8.4% | 0.00% | – |
Q4 2023 | $569,311 | +3.0% | 38,132 | +11.4% | 0.00% | – |
Q3 2023 | $552,863 | -61.9% | 34,233 | -2.0% | 0.00% | -100.0% |
Q2 2023 | $1,449,222 | -28.2% | 34,921 | +4.1% | 0.00% | 0.0% |
Q1 2023 | $2,017,938 | -38.2% | 33,554 | -24.6% | 0.00% | 0.0% |
Q4 2022 | $3,265,762 | -2.7% | 44,523 | +0.8% | 0.00% | -50.0% |
Q3 2022 | $3,356,000 | +8.5% | 44,168 | -0.8% | 0.00% | +100.0% |
Q2 2022 | $3,093,000 | -17.1% | 44,509 | -1.1% | 0.00% | 0.0% |
Q1 2022 | $3,729,000 | +8.2% | 45,013 | -1.9% | 0.00% | 0.0% |
Q4 2021 | $3,447,000 | -50.3% | 45,905 | -23.1% | 0.00% | -66.7% |
Q3 2021 | $6,932,000 | -42.0% | 59,667 | +10.8% | 0.00% | -40.0% |
Q2 2021 | $11,943,000 | +58.4% | 53,841 | -5.6% | 0.01% | +66.7% |
Q1 2021 | $7,540,000 | -23.0% | 57,041 | +0.8% | 0.00% | -40.0% |
Q4 2020 | $9,796,000 | +67.1% | 56,611 | +7.5% | 0.01% | +66.7% |
Q3 2020 | $5,862,000 | +37.6% | 52,661 | -26.7% | 0.00% | 0.0% |
Q2 2020 | $4,261,000 | -65.5% | 71,861 | -60.8% | 0.00% | -66.7% |
Q1 2020 | $12,344,000 | -19.0% | 183,310 | +1.4% | 0.01% | 0.0% |
Q4 2019 | $15,237,000 | +39.1% | 180,810 | +23.4% | 0.01% | +28.6% |
Q3 2019 | $10,957,000 | +43.1% | 146,520 | +21.0% | 0.01% | +40.0% |
Q2 2019 | $7,657,000 | +47.6% | 121,100 | +12.4% | 0.01% | +66.7% |
Q1 2019 | $5,188,000 | +45.5% | 107,700 | +1.1% | 0.00% | 0.0% |
Q4 2018 | $3,566,000 | -36.4% | 106,500 | -0.5% | 0.00% | -25.0% |
Q3 2018 | $5,607,000 | +68.4% | 107,000 | +0.6% | 0.00% | +100.0% |
Q2 2018 | $3,330,000 | +88.1% | 106,400 | +31.0% | 0.00% | +100.0% |
Q1 2018 | $1,770,000 | +14.0% | 81,200 | +5.6% | 0.00% | 0.0% |
Q4 2017 | $1,553,000 | +1.8% | 76,900 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,526,000 | +16.7% | 76,900 | +1.7% | 0.00% | 0.0% |
Q2 2017 | $1,308,000 | +175.4% | 75,600 | +28.8% | 0.00% | – |
Q1 2017 | $475,000 | -5.0% | 58,700 | -7.8% | 0.00% | – |
Q4 2016 | $500,000 | -19.5% | 63,700 | -12.4% | 0.00% | -100.0% |
Q3 2016 | $621,000 | -26.8% | 72,700 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $848,000 | +205.0% | 72,700 | +278.6% | 0.00% | – |
Q1 2016 | $278,000 | – | 19,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |